ESC 365 - Survival benefit of guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis

ESC Professional Premium Access

Survival benefit of guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis

Session: Optimisation of heart failure treatment

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Doctor E. Tan (Singapore, SG)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Elinor Tan

National University Hospital, Singapore (Singapore)

0 follower

8 more presentations in this session

Up-titration of Guideline Directed Medical Therapy (GDMT) and the occurrence of side effects in Heart Failure with reduced Ejection Fraction (HFrEF)

Speaker: Doctor N. Panagiotides (Vienna, AT)

Visit-to-visit changes in heart rate in heart failure: a pooled participant-level analysis of the PARADIGM-HF and PARAGON-HF trials

Speaker: Doctor H. Lu (Lausanne, CH)

Use and associations with mortality/morbidity of guideline-directed medical therapy use in heart failure with improved ejection fraction: a PS-matched analysis from the swedish heart failure registry

Speaker: Doctor C. Basile (Naples, IT)

SGLT2 inhibitors are associated with development of heart failure with improved ejection fraction

Speaker: Doctor X. Wang (Shanghai, CN)

Differences in the optimization of pharmacological treatment in patients with heart failure and reduced ejection fraction and advanced chronic kidney disease.

Speaker: Doctor A. Recio Mayoral (Seville, ES)

Access the full session

Optimisation of heart failure treatment

Speakers: Doctor E. Tan, Doctor N. Panagiotides, Doctor H. Lu, Doctor C. Basile, Doctor X. Wang...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources